NYSE:WAT - Waters Stock Price, Forecast & News

Waters' stock was trading at $184.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, WAT stock has decreased by 1.0% and is now trading at $182.31. View which stocks have been mosted impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Waters.

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Waters.

Waters Co. (NYSE:WAT) posted its quarterly earnings data on Tuesday, February, 4th. The medical instruments supplier reported $3.20 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.01 by $0.19. The medical instruments supplier earned $716 million during the quarter, compared to analyst estimates of $714.34 million. Waters had a net margin of 24.61% and a return on equity of 172.16%. The firm's revenue was up .1% on a year-over-year basis. During the same period in the previous year, the company posted $2.87 EPS. View Waters' earnings history.

Waters announced that its Board of Directors has approved a stock repurchase program on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 18.2% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its shares are undervalued.

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.80.

11 analysts have issued 12 month price objectives for Waters' stock. Their forecasts range from $150.00 to $230.00. On average, they expect Waters' share price to reach $189.71 in the next year. This suggests a possible upside of 4.1% from the stock's current price. View analysts' price targets for Waters.

Media headlines about WAT stock have been trending very negative this week, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Waters earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutWaters.

Waters saw a decrease in short interest during the month of March. As of March 13th, there was short interest totaling 4,335,600 shares, a decrease of 7.8% from the February 27th total of 4,700,000 shares. Based on an average daily trading volume, of 514,100 shares, the days-to-cover ratio is currently 8.4 days. Currently, 7.0% of the shares of the stock are sold short. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Alibaba Group (BABA), Home Depot (HD), Raytheon (RTN), Verizon Communications (VZ), CVS Health (CVS), Procter & Gamble (PG), Cisco Systems (CSCO) and Texas Instruments (TXN).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $182.31.

Waters has a market capitalization of $11.33 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe. View additional information about Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]